Aller au contenu principal
Accès ouvert déclaré 2026 article

Process Analytical Technology Integration in 3D Printing Processes: Benefits and Challenges

0Citations signalées, ce qui n’est pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Three-dimensional printing (3DP) manufacturing technologies will transform pharmaceutical industry, offering the ability to produce personalized medicine and complex dosage forms with diverse geometries, with the advantage of on-demand dispensing. Maintaining consistent product quality and regulatory compliance pose major challenges in the current landscape due to the inherent variability and multivariate complexity of 3DP. Employing Process Analytical Technology (PAT) with Quality by Design (QbD) and continuous manufacturing (CM) principles provides the necessary framework for real-time monitoring (RTM), control, and understanding of critical process parameters and quality attributes. As a result, key PAT tools are now applied to various 3DP processes such as extrusion-based printing, powder bed fusion, and inkjet printing, utilizing spectroscopic, thermal, imaging, and emerging sensing technologies. Data generated from these tools are further processed using chemometric models, machine learning (ML), and multivariate data analysis for real-time decision-making and closed-loop control, thus enabling smart manufacturing. Although progress has been made, certain challenges remain regarding PAT, model transferability, validation, scalability, data management, and regulatory issues. This promotes a continuously evolving landscape for implementing PAT in 3DP that supports standardization, real-time release testing (RTRT), and lifecycle management. Emerging technologies focus on combining PAT with artificial intelligence (AI), digital twins, and automated feedback systems to develop self-regulating, adaptive 3DP platforms. This review highlights PAT's role as a key element in advancing pharmaceutical 3DP from experimental applications to robust, scalable, and regulatory-compliant manufacturing, offering a comprehensive overview of current technologies, data analytics, regulatory issues, challenges, and future directions in the field.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Process Analytical Technology Integration in 3D Printing Processes: Benefits and Challenges
Date Crossref
09/09/2026
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Additive Manufacturing and 3D Printing Technologies3D Printing in Biomedical ResearchInjection Molding Process and Properties

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.